PF-07321332, molecular model. The image shows the structure of PF-07321332, an antiviral drug developed by Pfizer which acts as a protease inhibitor in the treatment of COVID-19. In order to slow down the metabolism of PF-07321332, Ritonavir is added. As of 2021, the combination of PF-07321332 and Ritonavir is in phase II trials under the name Paxlovid.
| px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP27148775
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
Loading